The core purpose of the active ingredient in Амлодипин-Тева is applied in addressing two key conditions: high blood pressure (hypertension) and certain types of angina. This overall therapeutic focus supports the management of chronic cardiovascular conditions, helping to ease the overall symptom burden and manage conditions marked by increased physiological stress.

The medication is commonly used across conditions characterized by sustained elevated arterial pressure, such as Essential Hypertension, and is relevant for easing symptom clusters related to Episodic Chest Pain and Heaviness in Chronic Stable Angina and Vasospastic Angina.

The medication contributes to easing the symptom load by supporting a more stable blood pressure level, which may assist with maintaining a sense of stability, and is considered relevant for adults and, where appropriate, in pediatric patients aged 6 to 17 years. It is used to address distressing manifestations of chest discomfort and pressure, and the benefit is that it is considered relevant for easing symptoms that cluster as recurrent anginal manifestations.

“The therapeutic approach is relevant in contexts involving heightened systemic burden and assists in managing chronic symptomatic phases.”

---

Quick Fact: Supportive Management for Arterial Pressure Symptoms The medication assists with managing symptoms related to sustained elevated arterial pressure, contributing to improved day-to-day comfort and stability during symptomatic periods.

Regulatory References

1. NIH MedlinePlus Drug Information

Official Eligibility Rules for Амлодипин-Тева

Eligibility to use Амлодипин-Тева (Amlodipine) is defined strictly by regulatory labeling, outlining specific populations who are permitted, restricted, or prohibited from using the medicine. The medicine is primarily allowed for adults and for pediatric patients aged 6 to 17 years for the management of hypertension only, based on established safety and efficacy profiles.

---

Classification	Population/Condition	Restriction Status
Absolute Contraindications	Hypersensitivity to Amlodipine/Dihydropyridines	Must Not Use (Prohibited)
Absolute Contraindications	Severe Hypotension, Cardiogenic Shock	Must Not Use (Prohibited)
Condition-Based Restriction	Impaired Hepatic Function	Conditional Use (Requires Caution)
Age Restriction	Children younger than 6 years old	Use Not Established
Physiological Status	Pregnancy/Lactation	Not Recommended (Conditional)

---

Use is contraindicated in patients with conditions such as severe low blood pressure, any form of shock, or obstruction of the left ventricular outflow tract (e.g., severe Aortic Stenosis). Patients with impaired liver function are considered a restricted population and require caution, often initiating therapy with a low starting dose. While renal impairment does not typically necessitate a dose change, the safety and efficacy of the drug are not established in children under the age of six.

Interactions with other Medicines and Products

Official regulatory information describes specific interactions for Amlodipine that involve pharmacokinetic and pharmacodynamic mechanisms. Amlodipine is primarily metabolized by the CYP3A4 enzyme; therefore, co-administration with other drugs that affect this enzyme requires attention.

Interacting Product Categories and Restrictions

Product Category/Mechanism	Official Regulatory Constraint
Strong CYP3A4 Inhibitors (e.g., ketoconazole, clarithromycin)	May significantly increase Amlodipine exposure, necessitating monitoring for hypotension and potential Amlodipine dose reduction.
CYP3A4 Inducers (e.g., rifampin, St. John's wort)	May decrease Amlodipine plasma concentration, potentially reducing its clinical effectiveness.
Dantrolene (Intravenous)	Concomitant use is restricted due to the established risk of cardiovascular collapse and hyperkalemia.
Simvastatin	Amlodipine increases Simvastatin exposure; the maximum dose of Simvastatin is limited to 20 mg daily when co-administered.
Immunosuppressants (e.g., cyclosporine, tacrolimus)	Amlodipine increases the systemic exposure of these agents, requiring frequent monitoring of their blood levels and subsequent dose adjustment.
Other Antihypertensive Agents	Potential for additive pharmacodynamic effects, requiring careful monitoring for increased risk of symptomatic hypotension.

Consumption of grapefruit or grapefruit juice must be avoided as it can increase the systemic exposure of Amlodipine. For elderly patients, co-administration with strong CYP3A4 inhibitors may pose an increased risk of hypotension.

Selective Blockade of L-Type Calcium Channels

The drug's primary action is the selective antagonism of voltage-dependent L-type calcium channels (CaV1.2), predominantly those found on the membranes of vascular smooth muscle cells. By inhibiting the influx of extracellular calcium ions (Ca^2+) into the cell, Amlodipine prevents the activation of the cellular machinery required for muscle contraction.

---

Modulation of Arterial Smooth Muscle Tone and Afterload

This molecular blockade directly leads to the relaxation and widening of peripheral arteries, a process known as vasodilation, which modulates the systemic vascular tone. The resulting reduction in systemic vascular resistance (SVR), or afterload, decreases the mechanical pressure against which the heart must pump blood.

---

Mechanism-Sustaining Binding Kinetics

Amlodipine is characterized by slow association and dissociation kinetics at its target channel. This prolonged interaction ensures that the inhibition of calcium influx is sustained throughout the 24-hour dosing interval, maintaining the resulting physiological alteration to circulatory dynamics.

How to use Амлодипин-Тева (Amlodipine) — Administration Guidelines

The administration of Amlodipine follows established guidelines ensuring consistent, long-term daily use. The medicine is available as oral tablets in strengths of 2.5 mg, 5 mg, and 10 mg.

Administration Scope

Feature	General Administration Details
Route of administration	Oral administration in tablet form.
Dosing schedule (Adults)	Initial dose is typically 5 mg once daily; maximum dose is 10 mg once daily.
Timing in relation to meals	May be taken with or without food.
Preparation requirements	Tablets should be swallowed whole with liquid. Co-administration with grapefruit or grapefruit juice is generally not recommended.
Age-group administration rules	Older adults and patients with hepatic impairment may be started on a lower initial dose of 2.5 mg once daily. Pediatric patients (6–17 years) with hypertension are prescribed 2.5 mg to 5 mg once daily.
Missed-dose rules	If a dose is missed, take it as soon as it is remembered, unless it is close to the next scheduled dose, in which case the missed dose should be skipped. Never take two doses at once.
Special procedural conditions	Dosage adjustments (titration) should be performed slowly, typically over a 7 to 14 day interval, to fully assess the response to each dose level.

---

Instruction Classifications (High-Level)

Classification	Description
Administration method type	Oral
Frequency pattern	Once daily
Use-context constraints	Use with caution and lower starting doses in older or hepatically impaired populations.

---

Resulting Procedural Structure

The regimen follows a once-daily oral schedule using defined initial and maximum dose limits. This regimen incorporates a slow titration period of one to two weeks between any dose adjustment to allow drug levels to stabilize, thereby structuring the long-term, chronic administration of the medicine.

Recent Clinical Evidence for Amlodipine

Clinical research has widely established the use of amlodipine, the active ingredient in Amlodipin-Teva, for managing high blood pressure (hypertension) and chronic stable or vasospastic angina (chest pain). Studies consistently indicate its ability to help achieve target blood pressure goals in adult populations.

---

Efficacy in Hypertension and Cardiovascular Outcomes

Major randomized controlled trials (RCTs) have examined the long-term effectiveness of amlodipine-based treatment regimens. These large-scale studies suggest that controlling blood pressure with amlodipine-based therapy may be associated with reductions in the incidence of certain cardiovascular events, such as non-fatal myocardial infarction (heart attack) and stroke, when compared to other reference treatments or placebo. In patients with coronary artery disease documented by angiography, amlodipine use, in the absence of heart failure, has been associated with a lower risk of hospitalization for angina and a reduced need for certain coronary procedures.

---

Use in Angina

For patients with chronic stable angina, clinical evidence shows that taking amlodipine once daily may help to increase total exercise time and reduce the frequency of anginal attacks. In trials focused on exercise-induced angina, a greater increase in symptom-limited exercise time was noted at the 10 mg dosage compared to the 5 mg dosage, suggesting a dose-related effect in managing chest pain symptoms. The medicine's effect of relaxing blood vessels is central to its utility in helping to manage both hypertension and angina.

---

Comparative Findings

In head-to-head trials against other classes of blood pressure medication, amlodipine has demonstrated comparable effectiveness in blood pressure lowering and, in some cases, was observed to reduce blood pressure variability over a 24-hour period. However, clinical benefits and outcomes can vary significantly between individuals. Decisions about initial therapy or combination regimens depend on a patient’s overall health profile, including the presence of other medical conditions.

Key Studies & References Amlodipine and Landmark Trials: A Review (Covers trials showing efficacy in HTN and angina, and effects on CV outcomes)

Common questions about Амлодипин-Тева (FAQ)

---

Q: Как долго нужно принимать Амлодипин-Тева, чтобы увидеть эффект?

According to official product information, the maximum concentration of the drug in the blood is typically reached 6–12 hours after taking a dose. Because this medicine is designed for stable, long-term use, it usually takes about 7 to 8 days of consecutive daily dosing for the levels to stabilize. The full intended effect on blood pressure is generally assessed within 2 weeks after any change in dose.

---

Q: Амлодипин-Тева и обычный Амлодипин — это одно и то же?

Амлодипин-Тева contains amlodipine as its active ingredient. This is the same active ingredient found in other formulations of amlodipine. 'Тева' simply identifies the pharmaceutical company that produces this specific formulation of the oral tablet.

---

Q: Амлодипин-Тева нужно принимать утром или вечером?

Regulatory documents state that this medicine should be taken once daily. Official guidance does not specify a mandatory time of day (morning or evening) for administration, but effectiveness is maintained for at least 24 hours. Regulatory documents emphasize the importance of consistent daily use.

---

Q: Можно ли пить Амлодипин-Тева натощак или обязательно после еды?

Official information indicates that Амлодипин-Тева may be taken with or without food. The presence of food in the stomach does not significantly change how the active ingredient is absorbed by the body.

---

Q: Что делать, если пропустил прием таблетки?

Official rules define the procedure: taking the missed dose as soon as it is remembered, unless the time is close to the next scheduled dose, in which case the missed dose should be skipped entirely. The regulatory documents explicitly prohibit taking two doses at once to make up for a missed dose.

---

Q: Можно ли принимать Амлодипин-Тева при наличии проблем с почками?

Regulatory guidance indicates that the medicine is not significantly processed by the kidneys. Therefore, patients with kidney impairment may typically receive the usual initial dose, and no dose adjustment is generally required based on regulatory guidance.

---

Q: Можно ли пить кофе или алкоголь при приеме Амлодипина-Тева?

Regulatory documents describe the use of alcohol as potentially having additive blood pressure lowering effects, which could increase the risk of side effects like dizziness and fainting. Official labeling does not contain specific information or restrictions regarding the consumption of coffee or caffeine.

---

Q: Какие есть известные взаимодействия Амлодипина-Тева с лекарствами от простуды?

The official documentation lists specific categories of interacting medicines, such as those that inhibit or induce the CYP3A4 enzyme, as these can affect how the body handles amlodipine. Official sources focus on medication categories; information on specific over-the-counter products is not provided in general regulatory documents.

---

Q: Снижает ли Амлодипин-Тева частоту сердечных сокращений?

Amlodipine is classified as a peripheral arterial vasodilator and is not generally associated with a significant decrease in heart rate in therapeutic doses. Its primary effect is the relaxation and widening of peripheral arteries to reduce blood pressure.

---

Q: Почему врачи часто назначают Амлодипин вместе с другими лекарствами?

Amlodipine is officially indicated for use alone or in combination with other antihypertensive agents. Combination therapy may be utilized when the patient’s target blood pressure is not fully achieved with a single medicine alone.

---

Q: Какие продукты питания могут снизить эффективность Амлодипина-Тева?

Official information states that consumption of grapefruit or grapefruit juice is generally not recommended or must be avoided. This is because grapefruit can increase the systemic exposure of amlodipine, potentially leading to increased side effects.

---

Q: Разрешен ли Амлодипин-Тева для пожилых людей?

Official guidance generally allows the use of amlodipine in older adults. However, regulatory documents note that older adults may clear the drug from their bodies more slowly, and a lower initial dose may be considered.

---

Q: Влияет ли Амлодипин-Тева на уровень сахара в крови?

Official regulatory documents and labeling do not report known or clinically significant adverse effects related to blood sugar levels or known interactions with clinical laboratory tests for glucose.

---

Q: Как Амлодипин-Тева влияет на стенокардию?

Amlodipine is indicated for the treatment of both chronic stable angina and Prinzmetal's angina (vasospastic angina). It helps manage chest pain by relaxing blood vessels, which assists in increasing the flow of oxygen to the heart muscle.

---

Q: Может ли Амлодипин-Тева помочь при отечности лица?

The most commonly reported swelling is peripheral edema, typically affecting the ankles and feet. However, regulatory documents also list Angioedema (swelling of the face, lips, or throat) as a rare but serious adverse reaction documented in postmarketing reports.

---

Q: Через сколько времени начинает действовать одна таблетка?

According to pharmacokinetic data, the concentration of the medicine reaches its peak level in the blood between 6 and 12 hours after a single dose.

---

Q: Что произойдет, если принять две таблетки вместо одной?

Taking an amount exceeding the maximum dose is described in regulatory documents as potentially resulting in excessive widening of blood vessels. This may lead to marked low blood pressure (hypotension) and possibly a rapid heartbeat (reflex tachycardia).

---

Q: Когда Амлодипин-Тева полностью выводится из организма?

The measure used to describe how long the medicine remains in the body (the terminal elimination half-life) is approximately 30 to 50 hours in adults with normal function. This long half-life means it takes several days for the medicine to be largely cleared from the system.

---

Q: На что нужно обратить внимание при приеме этого препарата?

Official regulatory documents draw attention to potential risks such as symptomatic low blood pressure (hypotension). Warnings note that the drug is metabolized by the liver, and caution and careful consideration of dosage are necessary in patients with liver impairment.

---

Q: Влияет ли Амлодипин-Тева на память или концентрацию?

Common side effects listed in regulatory documents include central nervous system effects such as dizziness and somnolence (sleepiness). Additionally, less common or rarely reported effects have included amnesia (memory loss) and confusion.

---

Q: Влияет ли препарат на печень?

Amlodipine is broken down extensively by the liver, and regulatory documents state that caution is required in patients with severe liver impairment. Rare but serious effects, such as jaundice and signs of liver-related toxicity, have been documented in postmarketing experience.

---

Q: Через какое время после начала приема нужно снова измерить давление?

Official guidance for clinical practice states that when adjusting the dose, it should be done slowly, typically waiting an interval of 7 to 14 days. This waiting period allows the drug levels to stabilize fully so that the patient's response can be accurately assessed.

---

Q: Может ли препарат вызвать бессонницу?

Official documentation lists insomnia, or difficulties with sleep, as an uncommon adverse reaction associated with the use of amlodipine.

---

Q: Что нужно знать о взаимодействии Амлодипина-Тева с Варфарином?

Official drug interaction studies indicate that amlodipine did not significantly change the way warfarin works to thin the blood. This suggests that a major interaction between the two medicines is not typically expected.

How to Store and Dispose of Amlodipine Teva

Amlodipine Teva (amlodipine besylate) must be stored according to official regulatory labeling to ensure its stability.

Storage Requirements

Condition	Requirement
Temperature	Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection	Keep away from moisture and excessive heat.
Container	Keep in the original container and maintain it tightly closed.
Child Safety	Store out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired tablets must follow official guidance. The product should be disposed of through a community drug take-back program where available. If a take-back option is unavailable, the medicine should be mixed with an undesirable substance (such as dirt) and sealed in a container before being placed in the trash. It is officially advised not to flush Amlodipine Teva down the toilet or sink.